Last reviewed · How we verify
A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants
The main purpose of this study is to evaluate the relative bioavailability of JNJ-64417184, formulated as a test formulation (tablet) compared to a reference formulation (suspension), administered orally in a fasted state, in healthy participants.
Details
| Lead sponsor | Janssen Research & Development, LLC |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 18 |
| Start date | Wed May 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jun 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy
Interventions
- JNJ-64417184 600 (Oral Tablet Formulation)
- JNJ-64417184 (Oral Suspension Formulation)
Countries
United States